Advantage Solutions did the thing companies do when their share price falls through the floor: on March 26 it effected a 1-for-25 reverse stock split, reclassifying every 25 shares into one. The purpose was not subtle. The company had received a Nasdaq notice on January 7 that its stock had fallen below the $1.00 minimum bid price, with a July 6 deadline to regain compliance, and a reverse split from sub-$1 to the low-$20s clears that bar mechanically. This is cosmetic financial engineering, and on its own it changes nothing about the business.

What is easy to miss behind the split is that the underlying operation is moving the right way. First-quarter 2026 revenue was about $869.6 million, up 5.8% year over year, led by the Experiential and Retailer Services segments. The company swung to operating income of $4.2 million from a loss a year earlier, and adjusted EBITDA rose 16.4% to $67.7 million with margin expanding to 7.8%. For a business the market had left for dead at a sub-$1 quote, that is a real operating recovery.

Under the Split
Cosmetics versus fundamentals
A reverse split to stay listed, over an operating line that is improving
Reverse split
1-for-25
Q1 revenue
$869.6M
Rev growth
+5.8%
Adj. EBITDA
$67.7M
Net loss
$71.8M
Source: Advantage Solutions Q1 2026 results and March 2026 reverse-split filing

Why the net loss is still enormous

The gap between a $67.7 million adjusted-EBITDA quarter and a $71.8 million net loss is where the real story lives. That loss was driven largely by higher income-tax expense and roughly $20.4 million of third-party debt-issuance costs tied to a major refinancing. In other words, the operating engine is throwing off cash, but the capital structure is eating a large share of it, and the refinancing that triggered those costs is a reminder that leverage, not demand, is this company's binding constraint.

The reverse split fixed the quote. It did nothing for the leverage, which is the actual problem.

Why Neutral

The old bullish case was a private-label and services margin recovery that the market was underrating. The Q1 numbers give that thesis real support: revenue up, EBITDA up, margins expanding, operating income positive. But a company that has to reverse-split to keep its listing, and that runs a net loss this large because of financing costs, is not a clean bull. The recovery is genuine; the balance sheet keeps it honest. Neutral is where those two facts meet.

What to watch

Confirmation that compliance is formally regained, the trajectory of the segment margins that drove the EBITDA gain, and any progress on deleveraging after the refinancing. The operating line earns a second look. The balance sheet is why it stops at Neutral.

Disclosure

This article is independent editorial content and reflects the author's opinion and analysis as of the date of publication. It is not investment advice and should not be relied on as the basis for any investment decision. MicroCap Desk and its contributors received no compensation of any kind — cash, securities, or otherwise — from any company mentioned, or from any third party, in connection with this article. The author holds no position in any security mentioned. Information is drawn from sources believed reliable but is not guaranteed accurate or complete. Microcap securities carry a high risk of loss. Do your own research. See our full Disclosure.